The Molecular Mechanisms of Immune Cell Development and Function

免疫细胞发育和功能的分子机制

基本信息

项目摘要

PROJECT SUMMARY This proposal requests partial support for a 2023 Science Research Conference (SRC) sponsored by the Federation of American Societies for Experimental Biology (FASEB) on the subject of “Molecular Mechanisms of Immune Cell Development and Function”, the 11th conference in this highly successful series. This conference has been chosen for sponsorship by FASEB after a competitive re-evaluation every other year since its inception in summer 2003. The distinctive features of this conference are: (1) A strong emphasis on molecular biology of gene regulation in immune cell development and function, including new insights emerging from genome-wide and systems approaches; (2) Close integration of the study of molecular mechanisms of immune receptor gene recombination and diversification with concepts in genomic architecture and long-range genomic control; (3) Deliberate juxtaposition of research on different classes of immune cells to reveal larger patterns of shared use of molecular and developmental mechanisms; (4) An explicit focus on gene network and signaling network connections rather than “one gene at a time” studies to provide a comprehensive explanation of biological regulation; (5) Creation of sessions that integrate the major molecular/mechanistic themes of the meeting with immuno-oncology, gut homeostasis, and autoimmunity; (6) Integration of presentations from scientists at many career levels, from internationally renowned experts to junior postdoctoral fellows and graduate students, in an intensive, all-plenary program—allowing trainees easy access to experienced senior scientists who in turn gain an appreciation of the young people’s impact on the field, and (7) Implementation of our unique financial model in which invited speakers forego financial support for their participation to allow the use of the majority of funds to support trainees and young investigators who are establishing their independent careers. These distinctive features are designed around three specific aims: Aim 1—To disseminate the most recent and important advances and new paradigms in molecular immunology; Aim 2—To create a highly interactive, supportive, and collegial environment for the sharing of scientific knowledge between scientists at many different stages of training and career development, thereby facilitating new collaborations, broadening of professional and mentoring networks, and career development; and Aim 3—To enhance diversity among the individuals who participate in, contribute to, and achieve career advancement in the field of immunology and biological research more broadly. The support requested is crucial to make it possible for the most promising trainees and junior faculty in molecular immunology to publicly present their work in plenary sessions and interact in a small setting with leaders in their field. This meeting has received enthusiastic feedback from conference attendees of previous meetings, giving it a strong mandate for long-term continuation.
项目总结 该提案要求部分支持2023年科学研究会议(SRC),该会议由 美国实验生物学学会联合会(FASE B)关于“分子机制”的研究 免疫细胞发育和功能“,这是这个非常成功的系列中的第11次会议。这次会议 自成立以来每隔一年进行一次竞争性重新评估后,被选为FASE B的赞助商 2003年夏天。这次会议的鲜明特点是:(1)高度重视生物分子生物学 免疫细胞发育和功能中的基因调控,包括来自全基因组的新见解 (2)紧密结合免疫受体基因的分子机制研究 基因组结构和远程基因组控制概念的重组和多样化;(3) 故意将对不同类别免疫细胞的研究并列在一起,以揭示共享使用的更大模式 分子和发育机制;(4)明确关注基因网络和信号网络 联系,而不是“一次一个基因”的研究,以提供一个全面的生物学解释 管理;(5)设立会议,将会议的主要分子/机制主题与 免疫肿瘤学、肠道动态平衡和自身免疫;(6)整合了许多 职业水平,从国际知名专家到初级博士后研究员和研究生,在 密集的全会计划-使学员能够轻松接触到经验丰富的资深科学家,这些科学家反过来又能获得 赞赏年轻人对实地的影响,以及(7)实施我们独特的财务模式 其中,受邀发言者放弃了对他们的参与的财政支持,以允许使用大多数资金 以支持正在建立独立职业生涯的实习生和年轻调查人员。这些与众不同的 专题是围绕三个具体目标设计的:目标1-传播最新和最重要的 分子免疫学的进展和新范式;目标2-创建一个高度互动、支持和 为处于不同阶段的科学家分享科学知识创造了一个合伙的环境 培训和职业发展,从而促进新的合作,扩大专业和 辅导网络和职业发展;以及目标3--加强以下个人的多样性 在免疫学和生物研究领域参与、贡献和实现职业发展 更广泛地说。所要求的支持对于使最有前途的实习生和初级学员成为可能至关重要 分子免疫学教授在全体会议上公开介绍他们的工作,并在小范围内进行互动 与各自领域的领先者合作。本次会议得到了与会人员的热烈反馈 过去的几次会议,赋予了它长期延续的强大授权。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Amy Susan Weinmann其他文献

Amy Susan Weinmann的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Amy Susan Weinmann', 18)}}的其他基金

Genome organization, evolutionary structural variation, and gene regulation in immunity
免疫中的基因组组织、进化结构变异和基因调控
  • 批准号:
    10662147
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
Molecular characterization of the role for metabolites in immune cell differentiation
代谢物在免疫细胞分化中作用的分子表征
  • 批准号:
    10455211
  • 财政年份:
    2021
  • 资助金额:
    $ 1.15万
  • 项目类别:
Tet1 activity and function in helper T cells
辅助 T 细胞中的 Tet1 活性和功能
  • 批准号:
    8897261
  • 财政年份:
    2014
  • 资助金额:
    $ 1.15万
  • 项目类别:
Tet1 activity and function in helper T cells
辅助 T 细胞中的 Tet1 活性和功能
  • 批准号:
    8754547
  • 财政年份:
    2014
  • 资助金额:
    $ 1.15万
  • 项目类别:
Molecular Characterization of T-bet's Role in Immunity
T-bet 在免疫中的作用的分子表征
  • 批准号:
    6811196
  • 财政年份:
    2004
  • 资助金额:
    $ 1.15万
  • 项目类别:
Molecular Characterization of T-bet's Role in Immunity
T-bet 在免疫中的作用的分子表征
  • 批准号:
    8414841
  • 财政年份:
    2004
  • 资助金额:
    $ 1.15万
  • 项目类别:
Molecular Characterization of T-bet's Role in Immunity
T-bet 在免疫中的作用的分子表征
  • 批准号:
    8212463
  • 财政年份:
    2004
  • 资助金额:
    $ 1.15万
  • 项目类别:
Molecular characterization of the role for T-bet and Bcl-6 in immune cell metabolism and differentiation
T-bet 和 Bcl-6 在免疫细胞代谢和分化中作用的分子表征
  • 批准号:
    9241941
  • 财政年份:
    2004
  • 资助金额:
    $ 1.15万
  • 项目类别:
Molecular Characterization of T-bet's Role in Immunity
T-bet 在免疫中的作用的分子表征
  • 批准号:
    6892078
  • 财政年份:
    2004
  • 资助金额:
    $ 1.15万
  • 项目类别:
Molecular Characterization of T-bet's Role in Immunity
T-bet 在免疫中的作用的分子表征
  • 批准号:
    7230470
  • 财政年份:
    2004
  • 资助金额:
    $ 1.15万
  • 项目类别:

相似海外基金

Development of back bone vectors for chimeric antigen receptors against key molecules, CD47 and CD24, activating macrophages
开发针对关键分子 CD47 和 CD24 的嵌合抗原受体的骨干载体,激活巨噬细胞
  • 批准号:
    23K06728
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Engineering synthetic adhesion receptors to enhance the sensitivity of therapeutic chimeric antigen receptors
工程合成粘附受体以增强治疗性嵌合抗原受体的敏感性
  • 批准号:
    MR/W031353/1
  • 财政年份:
    2022
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Research Grant
CAREER: Engineering next-generation chimeric antigen receptors for cancer immunotherapy using phospho-proteomics
职业:利用磷酸蛋白质组学设计用于癌症免疫治疗的下一代嵌合抗原受体
  • 批准号:
    2145853
  • 财政年份:
    2022
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Continuing Grant
Construction of a drug discovery platform utilizing antigen receptors that regulate the quality of cancer immunity
利用调节癌症免疫质量的抗原受体构建药物发现平台
  • 批准号:
    22K06603
  • 财政年份:
    2022
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
用于基于自然杀伤细胞的免疫治疗的嵌合抗原受体的基于建模的设计
  • 批准号:
    10701754
  • 财政年份:
    2022
  • 资助金额:
    $ 1.15万
  • 项目类别:
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
用于基于自然杀伤细胞的免疫治疗的嵌合抗原受体的基于建模的设计
  • 批准号:
    10557760
  • 财政年份:
    2022
  • 资助金额:
    $ 1.15万
  • 项目类别:
Molecualr imaging for development of chimeric antigen receptors (CARs) resistant to T cell exhaustion
用于开发抗 T 细胞耗竭的嵌合抗原受体 (CAR) 的分子成像
  • 批准号:
    20H03536
  • 财政年份:
    2020
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Chimeric antigen receptors on regulatory T cells as a treatment strategy in auto-immune diseases.
调节性 T 细胞上的嵌合抗原受体作为自身免疫性疾病的治疗策略。
  • 批准号:
    437200
  • 财政年份:
    2020
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Studentship Programs
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
通过干细胞递送治疗性抗 HIV 嵌合抗原受体
  • 批准号:
    10542442
  • 财政年份:
    2020
  • 资助金额:
    $ 1.15万
  • 项目类别:
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
通过干细胞递送治疗性抗 HIV 嵌合抗原受体
  • 批准号:
    10321545
  • 财政年份:
    2020
  • 资助金额:
    $ 1.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了